Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 1/2 1

Status

Recruiting 3Unknown 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Carcinoma, Hepatocellular 8Nasopharyngeal Carcinoma 7Esophageal Neoplasms 6Neoplasm Metastasis 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Melanoma 4Advanced NSCLC 4Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Rectal Neoplasms 3Pancreatic Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Neoplasms 2Lung Neoplasms 2Locally Advanced Rectal Cancer 2Leukemia, Myeloid, Acute 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Biliary Tract Neoplasms 2Advanced Solid Tumors 2Advanced Solid Tumor 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 54130-nm albumin-bound paclitaxel 29Magnetic Resonance Spectroscopy 21Taxes 18Fluorouracil 18Specimen Handling 17Oxaliplatin 17Leucovorin 17Drug Therapy 17Albumin-Bound Paclitaxel 17Irinotecan 14pembrolizumab 13Cyclophosphamide 11Blood Specimen Collection 11Biopsy 11fludarabine 10Radiosurgery 9irinotecan sucrosofate 8folfirinox 6Magnetic Resonance Imaging 6Cetuximab 6Bevacizumab 6dehydroftorafur 5Surveys and Questionnaires 5Nivolumab 5Endoscopic Ultrasound-Guided Fine Needle Aspiration 5sintilimab 4olaparib 4balstilimab 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Pancreatic Neoplasms × Immune Checkpoint Inhibitors × Clear all
NCT06496373 2025-11-17

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Ruijin Hospital

Phase EARLY_PHASE1 Recruiting
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04954599 2025-10-07

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Maastricht University Medical Center

Phase 1/2 Recruiting
126 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT06326736 2024-03-22

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

Jinling Hospital, China

Phase EARLY_PHASE1 Recruiting
12 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡